Overview
Ambrish Mithal is a metabolic bone disease specialist with an H-index of 41 at Endocrinology (Member). Has been published in Cell reports, Nature communications. Based in Unknown, Unknown, Global.
Biography
Ambrish Mithal is an Indian endocrinologist and diabetologist. He secured MBBS from GSVM Medical College, master's degree (DM) from the All India Institute of Medical Sciences, New Delhi. Then he worked at Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow and, later, at Apollo Hospitals, New Delhi before joining Medanta the Medicity as Chairman, Division of Endocrinology and Diabetes where he worked from 2009 to 2019. Subsequently, he joined Max Health Care where he is the chairman and head of Endocrinology and Diabetes department.
Affiliations & Institutions
Research Impact
5 Publications
0 Total Citations
Publication Timeline
Published In
MetabolismDiabetes CareArch OsteoporosLancet Diabetes EndocrinolJ Endocrinol
Key Publications
Best practice recommendations for the diagnosis and management of hypoparathyroidism.
Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial).
The Indian Society for Bone and Mineral Research (ISBMR) position statement for the diagnosis and treatment of osteoporosis in adults.
Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial.
The role of glucagon-like peptides in osteosarcopenia.
Areas of Expertise
Medical Specialties
Media Archive